Medical Countermeasures | Global Biodefense

Menu

Latest stories

Project BioShield: Building a Better Medical Countermeasure Pipeline

BARDA Exercises First Option in Transition from BioThrax to AV7909 Anthrax Vaccine

More on pathogens and preparedness

Popular

Study Shows Virulence of B. pseudomallei Strain in Aerosol Model

by Global Biodefense July 23, 2019, 9:00 am
Modeling the Complexities of the Gut for Biodefense Applications

by Global Biodefense July 16, 2019, 11:50 am
In Fight Against Superbugs, BARDA Looks to Shore Up National Stockpile Countermeasures
USAID Seeks Innovations in Malaria Vaccine Development

by Global Biodefense June 16, 2019, 10:53 am
Crimean Congo Countermeasures: Researchers Investigate CCHFV-RDRp

by Global Biodefense June 11, 2019, 5:00 am
DARPA Seeks First-in-Human Therapeutic Interfering Particles Targeting Respiratory Viruses

by Global Biodefense May 27, 2019, 9:30 am
FDA Authorizes Marketing of First Diagnostic Test for Zika Virus Antibodies
Daiichi Sankyo Apologizes for Not Meeting Vaccine Production Milestone for Pandemic Preparedness

by Global Biodefense May 22, 2019, 9:03 am
Popular

Phage Therapy to Prevent Cholera Infections – and Possibly Those Caused by Other Deadly Bacteria

by Andrew Camilli and Minmin Yen May 19, 2019, 4:33 pm
Popular

Army Planning to Begin User Acceptance Testing of Malaria Drug Tafenoquine

by Global Biodefense April 21, 2019, 10:13 am
Radiation Nuclear Countermeasures Centralized Dosimetry Harmonization Effort
Ology Bioservices Awarded DoD Contract for Countermeasures Against Bioweapons

by Global Biodefense April 15, 2019, 8:16 am

Congratulations. You've reached the end of the internet.

Back to Top